5Balfour JA,Fitton A,Barradell LB.Lornixicam:A review of its pharmacology and therapeutic potential in the management of painful and in flammatory conditions[J].Drugs,1996,51 (4):639-657.
6Radhofer WS,Rabasseda X.Lornoxicam,a new potent NSAIDs with an improved tolerability profile[J].Drugs of Today,2000,36 (1):55-76.
7Mengle GL,Hubbard RC,Karim A,et al.A study of the platelet effects of SC-58653,a novel COX-2 selective inhibitor[J].Arthritis Rheum,1997,40(Suppl 9):S93.
8Simon LS,Weaver AL,Graam DY,et al.Antiinflammatory and upper gastrointestinal effects of celcoxib in rheumatoid arthritis[J].JAMA,1999,282(20):1 921 -1 928.
9Lefkowith JB.Cyclooxygenase-2 specificity and its clinical implications[J].Am J Med,1999,106(5B):43S-50S.
10Simon LS,Lanza FL,Lisky PE,et al.Preliminary study of the safety and efficacy of SC -58635,a novel cyclooxygenase -2 inhibitor[J].Arthritis Rheum,1998,41(9):1 591 -1 602.
